OCUPHIRE PHARMA INC. - COMMON STOCK
1.5800
21-6月-24 15:59:52
15 分の遅延
株式
-0.0200
-1.25%
本日の幅
1.5450 - 1.6450
ISIN
N/A
ソース
NASDAQ
-
06 6 2024 07:57:22 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 07:14:52 提供 Nasdaq GlobeNewswire
-
08 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 2 2024 16:10:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
05 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 1 2024 16:10:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 11 2023 16:38:14 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
02 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 11 2023 16:52:46 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >